Tissue-specific Dose Optimization
Tissue-Specific Dose Optimization is a methodological framework within mutagen dose optimization that systematically tailors mutagen exposure levels to the physiological and genetic characteristics of distinct tissue types to maximize targeted mutagenic efficiency while minimizing nonspecific cellular damage.
3
Publications
115
Citations
18
Authors
7
Institutions
Publications per year
2017–2026
0
Parents
3
Lutetium-177 Radiopharmeceutical Therapy Extravasation Lessons Learned
Health Physics · 2022 · 11 citations
1–4 of 3
18
1
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 18
7
University College London
London, United Kingdom
1 h-index
2 publications
84 citations

Swedish University of Agricultural Sciences
Uppsala, Sweden
1 h-index
2 publications
74 citations

University of Bradford
Bradford, United Kingdom
1 h-index
6 publications
252 citations

University of East Anglia
Norwich, United Kingdom
1 h-index
2 publications
84 citations
University of Washington
Seattle, United States
1 h-index
4 publications
144 citations

Cancer Research UK
London, United Kingdom
1 h-index
2 publications
84 citations

KTH Royal Institute of Technology
Stockholm, Sweden
1 h-index
1 publications
37 citations
Fox Chase Cancer Center
Philadelphia, United States
1 publications
11 citations
1–8 of 7
1 publications · 36 citations
1
h-index
ChemComm · 1 publications · 42 citations
1
h-index
1 publications · 37 citations
1
h-index
1 publications · 11 citations
1–4